SCMP
Goldman Sachs’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-259,941
| Closed | -$4.67M | – | 4429 |
|
|
2017
Q4 | $4.67M | Sell |
259,941
-493,303
| -65% | -$8.85M | ﹤0.01% | 2336 |
|
|
2017
Q3 | $8.89M | Buy |
753,244
+637,485
| +551% | +$7.52M | ﹤0.01% | 2034 |
|
|
2017
Q2 | $1.22M | Sell |
115,759
-70,254
| -38% | -$738K | ﹤0.01% | 3059 |
|
|
2017
Q1 | $2.05M | Buy |
186,013
+16,624
| +10% | +$183K | ﹤0.01% | 2725 |
|
|
2016
Q4 | $2.3M | Sell |
169,389
-43,372
| -20% | -$588K | ﹤0.01% | 2635 |
|
|
2016
Q3 | $2.62M | Buy |
212,761
+135,689
| +176% | +$1.67M | ﹤0.01% | 2572 |
|
|
2016
Q2 | $846K | Sell |
77,072
-71,665
| -48% | -$787K | ﹤0.01% | 3045 |
|
|
2016
Q1 | $1.63M | Buy |
148,737
+31,377
| +27% | +$343K | ﹤0.01% | 2629 |
|
|
2015
Q4 | $2.03M | Buy |
117,360
+105,451
| +885% | +$1.82M | ﹤0.01% | 2512 |
|
|
2015
Q3 | $237K | Sell |
11,909
-59,315
| -83% | -$1.18M | ﹤0.01% | 3755 |
|
|
2015
Q2 | $1.17M | Buy |
71,224
+46,985
| +194% | +$772K | ﹤0.01% | 2872 |
|
|
2015
Q1 | $377K | Buy |
24,239
+87
| +0.4% | +$1.35K | ﹤0.01% | 3492 |
|
|
2014
Q4 | $345K | Buy |
24,152
+5,832
| +32% | +$83.3K | ﹤0.01% | 3603 |
|
|
2014
Q3 | $119K | Buy |
18,320
+3,746
| +26% | +$24.3K | ﹤0.01% | 4178 |
|
|
2014
Q2 | $101K | Buy |
14,574
+4,016
| +38% | +$27.8K | ﹤0.01% | 4181 |
|
|
2014
Q1 | $75K | Sell |
10,558
-9,460
| -47% | -$67.2K | ﹤0.01% | 4185 |
|
|
2013
Q4 | $188K | Buy |
20,018
+7,683
| +62% | +$72.2K | ﹤0.01% | 3909 |
|
|
2013
Q3 | $77K | Buy |
12,335
+846
| +7% | +$5.28K | ﹤0.01% | 4055 |
|
|
2013
Q2 | $76K | Buy |
+11,489
| New | +$76K | ﹤0.01% | 3841 |
|